NCT04973488View on ClinicalTrials.gov

Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 25, 2020

Primary Completion Date

January 10, 2021

Study Completion Date

January 10, 2021

Conditions
COVID-19 PneumoniaCOVID-19 Respiratory InfectionAcute Respiratory FailureAcute Respiratory Distress Syndrome
Interventions
OTHER

Therapeutic plasma exchange

The intervention is a combination between the procedure of Therapeutic plasma exchange and biological transfusion of convalescent plasma from donors that have have COVID-19

Trial Locations (1)

305500

"Municipal Hospital Dr. Teodor Andrei Lugoj", Lugoj

All Listed Sponsors
collaborator

"University of Medicine and Pharmacy Victor Babes Timisoara"

OTHER

lead

Novacescu Alexandru

OTHER

NCT04973488 - Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients | Biotech Hunter | Biotech Hunter